Place your ads here email us at info@blockchain.news
Overweight rating Flash News List | Blockchain.News
Flash News List

List of Flash News about Overweight rating

Time Details
2025-10-14
13:09
Piper Sandler Hikes Robinhood $HOOD Target to $155 and Palantir $PLTR to $201, Maintains Overweight — Crypto-Exposed HOOD in Focus

According to @StockMKTNewz, Piper Sandler raised its price target on Robinhood (HOOD) to 155 from 140 while maintaining an Overweight rating, and increased Palantir (PLTR) to 201 from 182 with Overweight unchanged, signaling bullish sell-side positioning into near-term trading catalysts; source: @StockMKTNewz, Oct 14, 2025. For trading impact, changes in analyst targets and recommendations are historically associated with abnormal returns and higher turnover around announcement dates, which can inform short-term momentum and liquidity strategies; source: Womack, Journal of Finance (1996). For crypto market read-through, Robinhood operates cryptocurrency trading that supports assets including BTC, ETH, and DOGE, making HOOD an equity proxy for retail crypto engagement and brokerage flows; source: Robinhood Crypto help center and Robinhood Markets, Inc. disclosures (2023–2024). Palantir’s core business is enterprise and government data analytics and AI software with no direct cryptocurrency revenue exposure, implying a less direct crypto linkage versus HOOD; source: Palantir Technologies Inc. 2023 Form 10-K.

Source
2025-10-06
16:00
Barclays Hikes AMD Price Target to $300 From $200, Keeps Overweight Rating - Trading Alert

According to @StockMKTNewz, Barclays raised its price target on AMD to $300 from $200 and maintained an Overweight rating. Source: @StockMKTNewz on X, Oct 6, 2025. The post did not provide the research rationale, EPS estimate changes, or target time frame. Source: @StockMKTNewz on X, Oct 6, 2025. No cryptocurrency or digital asset market implications were mentioned in the post. Source: @StockMKTNewz on X, Oct 6, 2025.

Source
2025-10-02
14:01
Morgan Stanley Hikes Apple AAPL Price Target to $298 and Google GOOGL to $270, Overweight Reiterated — Trading Take and Crypto Sentiment Read

According to @StockMKTNewz, Morgan Stanley raised its Apple (AAPL) price target to $298 from $240 while maintaining an Overweight rating, and lifted Alphabet/Google (GOOGL) to $270 from $210 with Overweight maintained, highlighting stronger Big Tech outlooks that traders will price into near-term order flow, source: @StockMKTNewz. The Apple target implies roughly a 24% increase and the Google target about a 29% increase versus prior estimates, a magnitude that can influence mega-cap leadership within the Nasdaq 100, source: @StockMKTNewz. Crypto desks track these upgrades because Bitcoin’s correlation with U.S. tech equities, including the Nasdaq 100, has been positive in several recent market regimes, linking equity risk sentiment with BTC performance, source: Kaiko Research 2024 cross-asset correlation analyses. Given the correlation context, traders often monitor BTC and ETH alongside moves in AAPL and GOOGL to gauge potential cross-asset risk appetite shifts on upgrade days, source: Kaiko Research 2024 cross-asset correlation analyses.

Source
2025-09-26
13:06
Morgan Stanley Raises Microsoft (MSFT) Price Target to 625, Reaffirms Overweight — Trading Update

According to @StockMKTNewz, on Sep 26, 2025 Morgan Stanley raised its Microsoft (MSFT) price target to 625 from 582 while maintaining an Overweight rating, source: @StockMKTNewz. The update contains only the new target and rating with no additional thesis or estimate details provided, source: @StockMKTNewz. The source does not mention any direct cryptocurrency market impact from this change, source: @StockMKTNewz.

Source
2025-09-18
12:27
JPMorgan Initiates CRISPR Therapeutics (CRSP) at Overweight with $70 Dec-2026 Price Target on Casgevy Momentum and $2B Cash

According to @stocktalkweekly, JPMorgan initiated coverage on CRISPR Therapeutics (CRSP) at Overweight with a Dec-2026 price target of $70 (source: @stocktalkweekly). The source reports JPMorgan sees CRSP nearing several portfolio inflection points, with partnered Casgevy and approximately $2 billion in cash providing valuation support (source: @stocktalkweekly). The source notes JPMorgan views CRSP’s setup and outlook as differentiated versus other gene-editing peers, with Casgevy’s commercial levers well understood (source: @stocktalkweekly). The source adds JPMorgan expects Casgevy sales to ramp and net profits to accrue to CRSP near term, and that a milder preconditioning regimen could help CRSP gain additional credit for its stake in the franchise (source: @stocktalkweekly). The source makes no mention of any cryptocurrency market impact (source: @stocktalkweekly).

Source
2025-05-19
12:22
AdvanSix $ASIX Upgraded to Overweight by Piper Sandler with $32 Price Target: Trading Insights and Crypto Market Impact

According to @stocktalkweekly, Piper Sandler has upgraded AdvanSix ($ASIX) to 'Overweight' from 'Neutral', raising its price target to $32 from $26. The upgrade is attributed to the anticipated earnings benefit from AdvanSix's ammonium sulfate business. This positive analyst action may increase institutional buying interest in ASIX, potentially impacting related chemical sector equities and commodity-linked crypto tokens. The move signals growing confidence in industrial and agricultural inputs, supporting a bullish outlook for both traditional equities and select crypto assets with exposure to the commodities sector (Source: @stocktalkweekly, May 19, 2025).

Source